Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | NAMPT | P43490 | 3/20 | 0.44 |
| ▸ | CDK2 | P24941 | 9/20 | 0.42 |
| ▸ | GSK3B | P49841 | 3/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.38 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.38 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12954106 | 0.87 | CYP19A1 (0.44) | CYP19A1NAMPTCDK2GSK3BOPRK1 | |
| SCHEMBL14613491 | 0.85 | GSK3B (0.39) | NAMPTCDK2GSK3BCCNA2CCNA1 | |
| SCHEMBL14613377 | 0.83 | GSK3B (0.42) | CDK2GSK3BCCNA2CCNA1 | |
| SCHEMBL13120678 | 0.82 | CDK2 (0.64) | CYP19A1CDK2GSK3BCCNA2CCNA1 | |
| SCHEMBL14545999 | 0.81 | CDK2 (0.54) | CDK2GSK3BCCNA2CCNA1 | |
| SCHEMBL13289053 | 0.80 | CDK2 (0.53) | CDK2GSK3BCCNA2CCNA1 | |
| SCHEMBL13289052 | 0.80 | CDK2 (0.53) | CYP19A1NAMPTCDK2GSK3BCCNA2 | |
| SCHEMBL14546000 | 0.80 | CDK2 (0.53) | CYP19A1NAMPTCDK2GSK3BCCNA2 | |
| SCHEMBL14613312 | 0.80 | CCR6 (0.40) | NAMPTCDK2CCNA2 | |
| SCHEMBL13289432 | 0.80 | CDK2 (0.47) | CYP19A1NAMPTCDK2GSK3BCCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1720882-B1 | PYRAZOLOPYRIMIDINE-DERIVATIVES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2011-01-05 | — | — | EP | disclosed |